Mayo Clinic researchers identify a potential new approach to treat HER2 positive breast cancer

(Mayo Clinic) Researchers at Mayo Clinic have identified an important new pathway by which HER2 positive breast cancers grow and have discovered that a dietary supplement called cyclocreatine may block the growth of HER2 positive breast cancer. Their findings were published today in Cell Metabolism.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news